drugset / Trial / NCT00977951
Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to further determine the safety and toleration of intradermal avotermin (Juvista), confirm accelerated healing and investigate genomic expression profiles
Timeline
- Start
- 2002-09
- Primary completion
- 2003-09
- Completion
- 2003-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avotermin | Protein / enzyme biologic | 50 ng | Other |
Indications
No indication recorded.